Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: A prospective study

Bone Marrow Transplantation

Volumn 22, Issue 9, 1998, Pages 883-888

  Lee, J H ^a,b   Lee, K H ^a   Kim, S ^a   Lee, J S ^a   Kim, W K ^a   Park, C J ^a   Chi, H S ^a   Kim, S H ^a  

^a University of Ulsan   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

BMT; Coagulation parameters; VOD

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 8; PROTEIN C; PROTEIN S; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; LIVER VEIN OBSTRUCTION; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0031740193     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701445     Document Type: Article

References (21)

1. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005-3020.
2. Buglin TP. Veno-occlusive disease of the liver complicating bone marrow transplantation. Bone Marrow Transplant 1994; 13: 1-4.
3. Shulman HM, Gown AM, Nugent DJ. Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistoehemical identification of the material within occluded central venules. Am J Hepatol 1987; 127: 549-558.
4. Catani L, Gugliotta L, Maitioli Belmonte M et al. Hypercoagulability in patients undergoing antologous or allogeneic BMT for hematologic malignancies. Bone Marrow Transplant 1993; 12- 253-259.
5. Harper PL, Jarvis J, Jennings I et al. Changes in the natural anticoagulants following bone marrow transplantation. Bone Marrow Transplant 1990; 5: 39-42.
6. Gordon B, Haire W, Kessinger A et al. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma. Bone Marrow Transplant 1991; 8: 497-502.
7. Collins PW, Gutteridge CN, O'Driscoll A et al. von Willebrand factor as a marker of endothelial cell activation following BMT. Bone Marrow Transplant 1992; 10: 499-506.
8. Faioni EM, Krachmalnicoff A, Bearman SI et al. Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts development of venocclusive disease of the liver. Blood 1993; 81: 3458-3462.
9. Haire WD. Antithrombin deficiency in special clinical syndromes - part II: hematologic malignancies and bone marrow transplantation, Semin Hematol 1995; 32: 56-60.
10. Collins P, Roderick A, O'Brien D et al. Factor VIIa and other haemostatic variables following bone marrow transplantation. Thromb Haemost 1994; 72: 28-32.
11. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive diesease of the liver and mulliorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267.
12. Salat C, Holler E, Reinhardt B et al. Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive disease. Bone Marrow Transplant 1994; 14: 747-750.
13. Park YD, Yasui M, Yoshimoto T et al. Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation. Bone Marrow Transplant 1997; 19: 915-920.
14. Salat C, Holler E, Wolf C et al. Laboratory markers of venoocclusive disease in the course of bone marrow and subsequent liver transplantation. Bone Marrow Transplant 1997; 19: 487-490.
15. Gordon B, Haire W, Ruby E et al. Prolonged deficiency of protein C following hematopoietic stem cell transplantation. Bone Marrow Transplant 1996; 17: 415-419.
16. Faioni EM, Mannucci PM. Venocclusive disease of the liver after bone marrow transplantation: the role of hemostasis. Leuk Lymphoma 1997; 25: 233-245.
17. Bross P, Ghazal H, Antabli B et al. Early drop in protein C and antithrombin III (AT III) levels is a predictor for the development venoocclusive disease in patients undergoing hematopoietic stem cell transplantation. Blood 1997; 90 (Suppl. 1): 220a (Abstr. 969).
18. Scrobohaci ML, Drouet L, Monem-Mansi A et al. Liver venoocclusive disease after bone marrow transplantaion changes in coagulation parameters and endothelial markers. Thromb Res 1991; 63: 509-519.
19. Salat C, Holler E, Kolb H-J et al. Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation. Blood 1997; 89: 2184-2188.
20. Morris JD, Harris RE, Hashmi R et al. Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation. Bone Marrow Transplant 1997; 20: 871-878.
21. Bearman SI, Shuhart MC, Hinds MS, McDonald GB. Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantation. Blood 1992; 80: 2458-2462.